Clinical Trial: Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07489066) titled 'Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC' on March 17.

Brief Summary: This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well it works when given alone or with chemotherapy. The study is for adults with early stage or locally advanced non-small cell lung cancer (NSCLC) that may or may not be removable with surgery.

The study is seeking participants who:

* Are aged 18 years or older

* Have either:

* Early-stage or locally advanced (Stage II or IIIA/B) NSCLC and are a candidate for neoa...